Talcum Powder Cancer Lawsuit

FDA Adds Talc Testing Standards for Asbestos Contamination in Cosmetic Products

New federal rules say that all cosmetic-grade talc must be tested for asbestos in the same way

Sunday, August 3, 2025 - The U.S. Food and Drug Administration (FDA) has formally announced new rules that say all companies that make talc-based cosmetics must use the same testing methods to look for asbestos contamination. This regulatory action is a response to years of worry from public health experts, consumers, and lawsuits that came about after asbestos was found in baby powder, body powders, and facial cosmetics. The new rule focuses on using transmission electron microscopy (TEM), which is more sensitive and trustworthy than prior approaches, to find even very small amounts of asbestos fibers. Talcum powder cancer lawyers who have helped thousands of people sue cosmetic companies for cancer caused by talcum powder say that the FDA's new rule will make it easier for them to demonstrate that companies should be held responsible for the safety of their products. Over the past ten years, there have been many talcum powder cancer lawsuits. This federal action shows that the government is going to start keeping a closer eye on a business that has been able to police itself for a long time.

Manufacturers thought talc was safe for decades, and they didn't have to send test findings to the FDA before putting goods on the market. This made it possible for a lot of different testing procedures to be used, and many of them weren't sensitive enough to find low yet hazardous levels of asbestos. The FDA's new rules say that all cosmetics that include talc must be tested using the same methods, and the results must be provided on request. The government said in its announcement that asbestos is a mineral that occurs naturally and is typically found near talc resources. If not adequately screened, it can readily get into the product during mining and processing. This possibility of contamination makes standardized testing not just smart but necessary. The FDA said that previous studies have detected asbestos fibers in cosmetics that were sold to both adults and children, often without the buyers' knowledge. These items were available in big retailers and online, which makes the necessity for federal action even clearer. Talcum powder cancer lawyers think that this new policy makes product liability cases stronger, especially those involving people who got mesothelioma or ovarian cancer after using the product for a long time.

The FDA's official statement says that the new guidelines came about because toxicologists, university researchers, and industry stakeholders all worked together to come up with them. The government said that older technologies like polarized light microscopy, which can't see fibers smaller than a particular size, will need to be replaced by newer ones like TEM. The new rules apply to both imported and made-in-the-USA cosmetics. They are part of a larger effort by the FDA to update how it regulates personal care items under the Modernization of Cosmetics Regulation Act (MoCRA). Consumer advocacy groups were happy with the news, but they told the FDA to do more. They wanted all testing data to be made public and for talc-based cosmetics to have warning labels on them until the risk is completely gone.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.